Department of Internal Medicine, Infectious Diseases and Psychosomatic Medicine, Ghent University Hospital, de Pintelaan 185, 9000 Ghent, Belgium.
Intensive Care Med. 2013 Mar;39(3):365-75. doi: 10.1007/s00134-012-2759-x. Epub 2012 Nov 28.
In ventilator-associated pneumonia (VAP), early appropriate antimicrobial therapy may be hampered by involvement of multidrug-resistant (MDR) pathogens.
A systematic review and diagnostic test accuracy meta-analysis were performed to analyse whether lower respiratory tract surveillance cultures accurately predict the causative pathogens of subsequent VAP in adult patients. Selection and assessment of eligibility were performed by three investigators by mutual consideration. Of the 525 studies retrieved, 14 were eligible for inclusion (all in English; published since 1994), accounting for 791 VAP episodes. The following data were collected: study and population characteristics; in- and exclusion criteria; diagnostic criteria for VAP; microbiological workup of surveillance and diagnostic VAP cultures. Sub-analyses were conducted for VAP caused by Staphylococcus aureus, Pseudomonas spp., and Acinetobacter spp., MDR microorganisms, frequency of sampling, and consideration of all versus the most recent surveillance cultures.
The meta-analysis showed a high accuracy of surveillance cultures, with pooled sensitivities up to 0.75 and specificities up to 0.92 in culture-positive VAP. The area under the curve (AUC) of the hierarchical summary receiver-operating characteristic curve demonstrates moderate accuracy (AUC: 0.90) in predicting multidrug resistance. A sampling frequency of >2/week (sensitivity 0.79; specificity 0.96) and consideration of only the most recent surveillance culture (sensitivity 0.78; specificity 0.96) are associated with a higher accuracy of prediction.
This study provides evidence for the benefit of surveillance cultures in predicting MDR bacterial pathogens in VAP. However, clinical and statistical heterogeneity, limited samples sizes, and bias remain important limitations of this meta-analysis.
在呼吸机相关性肺炎(VAP)中,多药耐药(MDR)病原体的参与可能会阻碍早期适当的抗菌治疗。
进行了系统评价和诊断测试准确性的荟萃分析,以分析下呼吸道监测培养物是否能准确预测成人患者随后发生 VAP 的病原体。由三位研究人员共同考虑进行选择和资格评估。从 525 项研究中检索到 14 项符合纳入标准(均为英文;发表于 1994 年以后),共 791 例 VAP 发作。收集了以下数据:研究和人群特征;纳入和排除标准;VAP 的诊断标准;监测和诊断 VAP 培养物的微生物学检查。对金黄色葡萄球菌、铜绿假单胞菌和不动杆菌引起的 VAP、MDR 微生物、采样频率进行了亚分析,并考虑了所有与最近的监测培养物。
荟萃分析显示监测培养物具有较高的准确性,在培养阳性 VAP 中,汇总敏感性高达 0.75,特异性高达 0.92。层次总结受试者工作特征曲线的曲线下面积(AUC)表明在预测多药耐药方面具有中等准确性(AUC:0.90)。每周采样>2/次(敏感性 0.79;特异性 0.96)和仅考虑最近的监测培养物(敏感性 0.78;特异性 0.96)与更高的预测准确性相关。
本研究为监测培养物预测 VAP 中 MDR 细菌病原体的益处提供了证据。然而,临床和统计学异质性、有限的样本量和偏倚仍然是该荟萃分析的重要局限性。